Test Code SFINC Cerebrospinal Fluid (CSF) IgG Index, Spinal Fluid
Specimen Required
Only orderable as part of a profile. For more information see SFIG / Cerebrospinal Fluid (CSF) IgG Index Profile, Serum and Spinal Fluid.
Specimen Type: Spinal fluid
Container/Tube: Sterile vial
Specimen Volume: 1 mL
Collection Instructions: Label specimen as spinal fluid.
Useful For
Aiding in the diagnosis of multiple sclerosis and other central nervous system inflammatory conditions
Method Name
Only orderable as part of a profile. For more information see SFIG / Cerebrospinal Fluid (CSF) IgG Index Profile, Serum and Spinal Fluid.
Nephelometry
Reporting Name
IgG Index, CSFSpecimen Type
CSFSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
CSF | Refrigerated (preferred) | 28 days | |
Frozen | 28 days | ||
Ambient | 14 days |
Reference Values
Only orderable as part of a profile. For more information see SFIG / Cerebrospinal Fluid (CSF) IgG Index Profile, Serum and Spinal Fluid.
CSF index: 0.00-0.85
CSF IgG: 0.0-8.1 mg/dL
CSF albumin: 0.0-27.0 mg/dL
CSF IgG/albumin: 0.00-0.21
CSF IgG synthesis rate: 0-12 mg/24 hours
Interpretation
Cerebrospinal fluid (CSF) IgG synthesis rate indicates the rate of increase in the daily CSF production of IgG in milligrams per day.
A result greater than 12 mg/24 hours is elevated.
A CSF index greater than 0.85 is elevated and indicative of increased synthesis of IgG.
Clinical Reference
1. Tourtellotte WW, Walsh MJ, Baumhefner RW, et al: The current status of multiple sclerosis intra-blood-brain-barrier IgG synthesis. Ann NY Acad Sci. 1984;436:52-67
2. Bloomer LC, Bray PF: Relative value of three laboratory methods in the diagnosis of multiple sclerosis. Clin Chem. 1981;27:2011-2013
3. Hische EA, van der Helm HJ: Rate of synthesis of IgG within the blood-brain barrier and the IgG index compared in the diagnosis of multiple sclerosis. Clin Chem. 1987;33:113-114
4. Thompson AJ, Banwell BL, Barkhof F, et al: Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 Feb;17(2):162-73. doi: 10.1016/S1474-4422(17)30470-2
5. Gurtner KM, Shosha E, Bryant SC, et al: CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes. Clin Chem Lab Med. 2018 Jun 27;56(7):1071-1080. doi: 10.1515/cclm-2017-0901
6. Rifai N, Horvath AR, Wittwer CT, eds: Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 6th ed. Elsevier; 2018
Day(s) Performed
Monday through Friday
Report Available
Same day/1 to 2 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
82042
82784
LOINC Code Information
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
INDEX | IgG Index, CSF | 14117-6 |
IGG_C | IgG, CSF | 2464-6 |
ALB_C | Albumin, CSF | 1746-7 |
AIGAC | IgG/Albumin, CSF | 2470-3 |
SRATE | Synthesis Rate, CSF | 14116-8 |